135 related articles for article (PubMed ID: 15804353)
21. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
Inagake H; Yamadori H; Inoue N; Mabuchi H; Ikeda N; Maekawa N
Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
[No Abstract] [Full Text] [Related]
22. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis.
Hu Y; Coates AR; Mitchison DA
Int J Tuberc Lung Dis; 2006 Mar; 10(3):317-22. PubMed ID: 16562713
[TBL] [Abstract][Full Text] [Related]
23. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
Saito T; Fukuhara Y
Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
[No Abstract] [Full Text] [Related]
24. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
[TBL] [Abstract][Full Text] [Related]
25. Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Cho SH; Warit S; Wan B; Hwang CH; Pauli GF; Franzblau SG
Antimicrob Agents Chemother; 2007 Apr; 51(4):1380-5. PubMed ID: 17210775
[TBL] [Abstract][Full Text] [Related]
26. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
Darby CM; Nathan CF
J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
[TBL] [Abstract][Full Text] [Related]
27. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
Khan A; Sarkar S; Sarkar D
Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
[TBL] [Abstract][Full Text] [Related]
28. [Experimental studies in vitro on the antituberculous activities of 27753RP (R.P), a semisynthetic derivative of griselimycine. IV. Antituberculous activities of R.P in vitro under various inadequate conditions for the growth of tubercle bacilli].
Shibata A
Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):43-9. PubMed ID: 6442175
[No Abstract] [Full Text] [Related]
29. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
30. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
Taneja NK; Tyagi JS
J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of BACTEC 460 TB system for rapid in vitro screening of drugs against latent state Mycobacterium tuberculosis H37Rv under hypoxia conditions.
Kharatmal S; Jhamb SS; Singh PP
J Microbiol Methods; 2009 Aug; 78(2):161-4. PubMed ID: 19454297
[TBL] [Abstract][Full Text] [Related]
32. Study on tuberactinomycin-N. I. In vitro Antibacterial activity of TUM-N on Tubercle bacilli isolated from patients.
Shimizu T
Jpn J Antibiot; 1974 Aug; 27(4):463-70. PubMed ID: 4140247
[No Abstract] [Full Text] [Related]
33. [Extensively drug-resistant tuberculosis].
Lange C; Grobusch MP; Wagner D
Dtsch Med Wochenschr; 2008 Feb; 133(8):374-6. PubMed ID: 18270922
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic Susceptibility Patterns of Mycobacterium tuberculosis Isolates from Guizhou Province of China Against 13 Antituberculosis Drugs.
Li N; Liao X; Chen L; Wang J; Liu M; Zhang H
Microb Drug Resist; 2015 Jun; 21(3):292-6. PubMed ID: 25599413
[TBL] [Abstract][Full Text] [Related]
35. Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations.
Heifets L; Lindholm-Levy P
Am Rev Respir Dis; 1992 May; 145(5):1223-5. PubMed ID: 1586071
[TBL] [Abstract][Full Text] [Related]
36. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
Endo K
Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
[No Abstract] [Full Text] [Related]
37. The interaction topology of Mycobacterium tuberculosis genes response to capreomycin and novel clues for more drug targets.
Zheng F; Xie J
J Cell Biochem; 2011 Oct; 112(10):2716-20. PubMed ID: 21678479
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis].
Tomoda T; Minami Y; Maekawa Y; Oi Y
Rinsho Byori; 1971 Jun; 19(6):423-6. PubMed ID: 4111341
[No Abstract] [Full Text] [Related]
39. [Susceptibility of drug-resistant tubercle bacilli isolated from pulmonary tuberculosis in patients to paromomycin (Aminosidine) (author's transl)].
Endo K
Jpn J Antibiot; 1974 Apr; 27(2):141-3. PubMed ID: 4136451
[No Abstract] [Full Text] [Related]
40. Metronidazole plus rifampin sterilizes long-term dormant Mycobacterium tuberculosis.
Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L
Antimicrob Agents Chemother; 2007 Apr; 51(4):1537-40. PubMed ID: 17242153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
